Clinical Trial

Magnetic Gastro-Ileal or Gastro-Jejunal Diversion Study ("MGI/MGJ Study")

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this clinical research study is to evaluate the feasibility of the GT Metabolic Solutions Magnet System, GJ Biofragmentable ("MagGJ System") for creation of a side-to-side anastomosis for gastro-ileal or gastro-jejunal diversion in obese adults.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2023-10-05; most recent amendment 2026-05-18.
Status change: Recruiting → Active, Not Recruiting 2026-05-18
Status change: Not Yet Recruiting → Recruiting 2023-10-27
Trial Details
NCT Number NCT06073457
Lead Sponsor GT Metabolic Solutions, Inc.
Conditions Obesity, Type 2 Diabetes
Enrollment 35 participants
Start Date 2023-11-06
Primary Completion 2026-04-17 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-20